CVS HEALTH CORPORATION
NYSE: CVS
▲
103.69
+1.69
+1.66%
1 Day
-
Open
102.88
-
Previous Close
102.00
-
Volume (Avg)
57 (4.86M)
-
Day's Range
102.44-104.34
-
52Wk Range
81.23-111.25
-
Market Cap.
133.91B
-
Dividend Rate (Yield)
2.20 (2.12%)
-
Beta
-
-
Shares Outstanding
-
-
P/E Ratio (EPS)
16.85 (-)
Top Stories
-
CVS Health Is Beating the Market: Is the Stock a Buy?
The Motley Fool 6 days ago -
Opinion: Protect Prescription Drug Affordability for California Families
Times of San Diego -
CVS says it plans to get into primary care by year-end
CNBC -
Analysis: What CVS Health’s interest in primary and home care means
MedCity News -
CVS' Primary Care Venture Treads On Providers, Pharma
HealthLeaders Media 17 hrs agoDeloitte reports that the increased attention on value-focused healthcare, combined with the primary care physician shortage, creates a perfect opportunity for retail pharmacies to disrupt the status quo.
-
Medicare Part D Business Acquisition to Boost CVS Caremark
TheStreet.com -
Health Employers Hired More In July Than June
Kaiser Health News -
CVS Caremark plans to stop tobacco products sales
The Daily Gazette -
CVS Caremark, McDermott Start This Week’s Marathon of Earnings
TheStreet.com -
Amwell tapped for CVS Health's virtual care platform
Modern Healthcare -
A Conversation with Alan Lotvin, M.D. | Part 2
Managed Healthcare Executive -
FTC to investigate CVS Caremark, Humana, other pharmacy benefit managers
Fox Business -
Client Profile: CVS/Caremark Corp
OpenSecrets.org -
Drugstores rush to bundle primary health care
Axios -
Report: CVS to Bid for Home Health Solutions Provider Signify Health
mhealthintelligence.com 1 day agoThe Wall Street Journal reported that CVS Health is eyeing an acquisition of Signify Health, which provides technology and analytics solutions to support home-based care initiatives.
-
From Kaiser Health News - Latest Stories:
Kaiser Health News -
CUNY SPH Foundation Board welcomes CVS Caremark CCIO Dr. Daniel Knecht
KXAN -
Drug company exec. on costs of prescriptions
CNN
